| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 9 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 22 |
| NetGPI | no | yes: 0, no: 22 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
| GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A0A3S7WW24
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 169 | 171 | PF00675 | 0.519 |
| CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.578 |
| CLV_PCSK_KEX2_1 | 157 | 159 | PF00082 | 0.525 |
| CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.578 |
| CLV_PCSK_PC1ET2_1 | 157 | 159 | PF00082 | 0.551 |
| CLV_PCSK_SKI1_1 | 111 | 115 | PF00082 | 0.349 |
| CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.399 |
| CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.357 |
| CLV_Separin_Metazoa | 71 | 75 | PF03568 | 0.348 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.527 |
| DOC_CYCLIN_RxL_1 | 84 | 94 | PF00134 | 0.441 |
| DOC_MAPK_gen_1 | 108 | 116 | PF00069 | 0.306 |
| DOC_MAPK_gen_1 | 157 | 166 | PF00069 | 0.366 |
| DOC_MAPK_gen_1 | 19 | 28 | PF00069 | 0.481 |
| DOC_MAPK_MEF2A_6 | 108 | 116 | PF00069 | 0.359 |
| DOC_MAPK_MEF2A_6 | 74 | 82 | PF00069 | 0.333 |
| DOC_PP1_RVXF_1 | 77 | 84 | PF00149 | 0.340 |
| DOC_PP2B_LxvP_1 | 26 | 29 | PF13499 | 0.437 |
| DOC_PP4_FxxP_1 | 53 | 56 | PF00568 | 0.407 |
| DOC_PP4_FxxP_1 | 83 | 86 | PF00568 | 0.379 |
| DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.367 |
| DOC_USP7_MATH_1 | 215 | 219 | PF00917 | 0.624 |
| DOC_USP7_MATH_1 | 234 | 238 | PF00917 | 0.423 |
| DOC_USP7_MATH_1 | 242 | 246 | PF00917 | 0.497 |
| DOC_USP7_MATH_1 | 29 | 33 | PF00917 | 0.451 |
| LIG_14-3-3_CanoR_1 | 178 | 184 | PF00244 | 0.495 |
| LIG_14-3-3_CanoR_1 | 25 | 29 | PF00244 | 0.400 |
| LIG_14-3-3_CanoR_1 | 3 | 7 | PF00244 | 0.529 |
| LIG_BIR_III_2 | 210 | 214 | PF00653 | 0.563 |
| LIG_CaM_IQ_9 | 143 | 159 | PF13499 | 0.410 |
| LIG_EH1_1 | 143 | 151 | PF00400 | 0.517 |
| LIG_eIF4E_1 | 76 | 82 | PF01652 | 0.366 |
| LIG_FHA_1 | 128 | 134 | PF00498 | 0.400 |
| LIG_FHA_1 | 141 | 147 | PF00498 | 0.323 |
| LIG_LIR_Apic_2 | 51 | 56 | PF02991 | 0.404 |
| LIG_LIR_Nem_3 | 131 | 137 | PF02991 | 0.540 |
| LIG_LRP6_Inhibitor_1 | 57 | 63 | PF00058 | 0.429 |
| LIG_MYND_1 | 16 | 20 | PF01753 | 0.474 |
| LIG_PCNA_yPIPBox_3 | 43 | 53 | PF02747 | 0.409 |
| LIG_Pex14_2 | 204 | 208 | PF04695 | 0.460 |
| LIG_SH2_STAT3 | 137 | 140 | PF00017 | 0.382 |
| LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.355 |
| LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.332 |
| LIG_SH3_3 | 9 | 15 | PF00018 | 0.510 |
| LIG_SH3_4 | 55 | 62 | PF00018 | 0.443 |
| LIG_SUMO_SIM_par_1 | 88 | 94 | PF11976 | 0.360 |
| LIG_TYR_ITIM | 133 | 138 | PF00017 | 0.373 |
| LIG_UBA3_1 | 89 | 97 | PF00899 | 0.439 |
| MOD_CK1_1 | 237 | 243 | PF00069 | 0.585 |
| MOD_CK1_1 | 32 | 38 | PF00069 | 0.419 |
| MOD_CK2_1 | 237 | 243 | PF00069 | 0.593 |
| MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.386 |
| MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.504 |
| MOD_N-GLC_1 | 127 | 132 | PF02516 | 0.378 |
| MOD_NEK2_1 | 190 | 195 | PF00069 | 0.449 |
| MOD_NEK2_1 | 2 | 7 | PF00069 | 0.507 |
| MOD_PKA_2 | 159 | 165 | PF00069 | 0.488 |
| MOD_PKA_2 | 2 | 8 | PF00069 | 0.533 |
| MOD_PKA_2 | 24 | 30 | PF00069 | 0.406 |
| MOD_Plk_1 | 32 | 38 | PF00069 | 0.421 |
| MOD_Plk_4 | 190 | 196 | PF00069 | 0.437 |
| MOD_Plk_4 | 32 | 38 | PF00069 | 0.431 |
| MOD_SUMO_rev_2 | 161 | 166 | PF00179 | 0.605 |
| MOD_SUMO_rev_2 | 205 | 213 | PF00179 | 0.553 |
| TRG_DiLeu_BaLyEn_6 | 85 | 90 | PF01217 | 0.424 |
| TRG_ENDOCYTIC_2 | 135 | 138 | PF00928 | 0.324 |
| TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.584 |
| TRG_Pf-PMV_PEXEL_1 | 67 | 71 | PF00026 | 0.386 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IMG2 | Leptomonas seymouri | 31% | 100% |
| A0A0N1PDB1 | Leptomonas seymouri | 75% | 99% |
| A0A0S4IZI9 | Bodo saltans | 52% | 100% |
| A0A0S4JXP9 | Bodo saltans | 28% | 81% |
| A0A1X0NWE3 | Trypanosomatidae | 67% | 100% |
| A0A1X0P2D2 | Trypanosomatidae | 27% | 100% |
| A0A3S7X2W2 | Leishmania donovani | 31% | 100% |
| A0A422N627 | Trypanosoma rangeli | 32% | 99% |
| A0A422NJN4 | Trypanosoma rangeli | 70% | 98% |
| A4HHV1 | Leishmania braziliensis | 30% | 100% |
| A4HYP5 | Leishmania infantum | 100% | 100% |
| A4I501 | Leishmania infantum | 31% | 100% |
| C9ZI86 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 100% |
| C9ZQF0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 32% | 82% |
| E9AIC3 | Leishmania braziliensis | 87% | 100% |
| E9AUL0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
| E9B0D1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
| Q4Q7V3 | Leishmania major | 31% | 100% |
| Q4QCX4 | Leishmania major | 95% | 100% |
| V5BCA8 | Trypanosoma cruzi | 34% | 99% |
| V5BVG0 | Trypanosoma cruzi | 70% | 100% |